Pembrolizumab shown to be less toxic than traditional treatments.UCLA researchers have found that a game-changing immunotherapy drug produces positive responses that are long-lasting and with...
Bristol-Myers Squibb has announced the first overall survival results from CheckMate -069, a Phase II trial evaluating the investigational combination of nivolumab and ipilimumab vs.
In a study appearing in JAMA, Antoni Ribas, M.D., Ph.D., of the University of California-Los Angeles, and colleagues examined tumor response and overall survival following administration of the...
With psoriasis affecting millions in the US, new data adds evidence for the links between the condition and a susceptibility to cardiac disease. Psoriasis is not just skin deep.
Ten years ago, Grant Lipman, MD, an emergency medicine physician, was working as a doctor for endurance athletes who were running 25 to 50 miles a day in various parts of the world, from China to...
A scientific paper released in the Journal of Drug Design, Development and Therapy shows the effectiveness of Zolav®, a new antibiotic, in treating acne.
New research highlights how vital it is to treat melanoma in an age-appropriate manner, suggesting anti-oxidants may be a more effective treatment for older patients.